首页> 外文期刊>International journal of toxicology >The Cosmetic Ingredient Review Program-Expert Safety Assessments of Cosmetic Ingredients in an Open Forum
【24h】

The Cosmetic Ingredient Review Program-Expert Safety Assessments of Cosmetic Ingredients in an Open Forum

机译:化妆品成分审查开放论坛中化妆品的专家安全评估

获取原文
获取原文并翻译 | 示例
       

摘要

The Cosmetic Ingredient Review (CIR) is a nonprofit program to assess the safety of ingredients in personal care products in an open, unbiased, and expert manner. Cosmetic Ingredient Review was established in 1976 by the Personal Care Products Council (PCPC), with the support of the US Food and Drug Administration (USFDA) and the Consumer Federation of America (CFA). Cosmetic Ingredient Review remains the only scientific program in the world committed to the systematic, independent review of cosmetic ingredient safety in a public forum. Cosmetic Ingredient Review operates in accordance with procedures modeled after the USFDA process for reviewing over-the-counter drugs. Nine voting panel members are distinguished, such as medical professionals, scientists, and professors. Three nonvoting liaisons are designated by the USFDA, CFA, and PCPC to represent government, consumer, and industry, respectively. The annual rate of completing safety assessments accelerated from about 100 to more than 400 ingredients by implementing grouping and read-across strategies and other approaches. As of March 2017, CIR had reviewed 4,740 individual cosmetic ingredients, including 4,611 determined to be safe as used or safe with qualifications, 12 determined to be unsafe, and 117 ingredients for which the information is insufficient to determine safety. Examples of especially challenging safety assessments and issues are presented here, including botanicals. Cosmetic Ingredient Review continues to strengthen its program with the ongoing cooperation of the USFDA, CFA, the cosmetics industry, and everyone else interested in contributing to the process.
机译:化妆品成分评论(CIR)是一种非营利组织,可在公开,无偏见和专业方式中评估个人护理产品中的成分安全性。化妆品成分审查是由个人护理产品委员会(PCPC)成立于1976年,并支持美国食品和药物管理局(USFDA)和美国消费联合会(CFA)。化妆品成分综述仍然是世界上唯一致力于在公共论坛上系统的,独立审查化妆品成分安全性的唯一科学计划。化妆品成分综述按照USFDA在审查过度抵抗药物的过程中建模的程序进行操作。九个投票小组成员区分,例如医疗专业人员,科学家和教授。三个非投资联络人由USFDA,CFA和PCPC指定,分别代表政府,消费者和行业。完成安全评估的年度税率通过实施分组和读取策略和其他方法加速约100至400多种成分。截至2017年3月,CIR审查了4,740种单独的化妆品成分,其中4,611确定,如使用或安全的安全,12项决定是不安全的,而且信息不足以确定安全性的117种成分。这里介绍了特别具有挑战性的安全评估和问题的例子,包括植物学。化妆品成分审查继续加强其计划,并通过USFDA,CFA,化妆品行业的持续合作,以及其他对该过程有兴趣的人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号